These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24349489)

  • 21. Multisystem disorder and limb girdle muscular dystrophy caused by LMNA p.R28W mutation.
    Türk M; Wehnert M; Schröder R; Chevessier F
    Neuromuscul Disord; 2013 Jul; 23(7):587-90. PubMed ID: 23746545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-Based Risk Stratification for Cardiac Disorders in
    Nishiuchi S; Makiyama T; Aiba T; Nakajima K; Hirose S; Kohjitani H; Yamamoto Y; Harita T; Hayano M; Wuriyanghai Y; Chen J; Sasaki K; Yagihara N; Ishikawa T; Onoue K; Murakoshi N; Watanabe I; Ohkubo K; Watanabe H; Ohno S; Doi T; Shizuta S; Minamino T; Saito Y; Oginosawa Y; Nogami A; Aonuma K; Kusano K; Makita N; Shimizu W; Horie M; Kimura T
    Circ Cardiovasc Genet; 2017 Dec; 10(6):. PubMed ID: 29237675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation.
    Hershberger RE; Hanson EL; Jakobs PM; Keegan H; Coates K; Bousman S; Litt M
    Am Heart J; 2002 Dec; 144(6):1081-6. PubMed ID: 12486434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies.
    Saj M; Bilinska ZT; Tarnowska A; Sioma A; Bolongo P; Sobieszczanska-Malek M; Michalak E; Golen D; Mazurkiewicz L; Malek L; Walczak E; Fidzianska A; Grzybowski J; Przybylski A; Zielinski T; Korewicki J; Tesson F; Ploski R
    BMC Med Genet; 2013 May; 14():55. PubMed ID: 23702046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
    van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
    Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a nonsense mutation in TNNI3K associated with cardiac conduction disease.
    Liu J; Liu D; Li M; Wu K; Liu N; Zhao C; Shi X; Liu Q
    J Clin Lab Anal; 2020 Sep; 34(9):e23418. PubMed ID: 32529721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of machine learning to classify high-risk variants of uncertain significance in lamin A/C cardiac disease.
    Bennett JS; Gordon DM; Majumdar U; Lawrence PJ; Matos-Nieves A; Myers K; Kamp AN; Leonard JC; McBride KL; White P; Garg V
    Heart Rhythm; 2022 Apr; 19(4):676-685. PubMed ID: 34958940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preprodynorphin gene mutation causes progressive cardiac conduction disease: A whole-exome analysis of a pedigree.
    Su JY; Zhang RF; Dong YX; Yang MH; Yin XM; Gao LJ; Li HH; Xia YL; Yang YZ
    Life Sci; 2019 Feb; 219():74-81. PubMed ID: 30611784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doubly heterozygous LMNA and TTN mutations revealed by exome sequencing in a severe form of dilated cardiomyopathy.
    Roncarati R; Viviani Anselmi C; Krawitz P; Lattanzi G; von Kodolitsch Y; Perrot A; di Pasquale E; Papa L; Portararo P; Columbaro M; Forni A; Faggian G; Condorelli G; Robinson PN
    Eur J Hum Genet; 2013 Oct; 21(10):1105-11. PubMed ID: 23463027
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic mutation of familial dilated cardiomyopathy based on next‑generation semiconductor sequencing.
    Lin XF; Luo JW; Liu G; Zhu YB; Jin Z; Lin X
    Mol Med Rep; 2018 Nov; 18(5):4271-4280. PubMed ID: 30221713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overlapping syndrome with familial partial lipodystrophy, Dunnigan variety and cardiomyopathy due to amino-terminal heterozygous missense lamin A/C mutations.
    Subramanyam L; Simha V; Garg A
    Clin Genet; 2010 Jul; 78(1):66-73. PubMed ID: 20041886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-exome sequencing identifies a novel mutation of GPD1L (R189X) associated with familial conduction disease and sudden death.
    Huang H; Chen YQ; Fan LL; Guo S; Li JJ; Jin JY; Xiang R
    J Cell Mol Med; 2018 Feb; 22(2):1350-1354. PubMed ID: 29077258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional consequences of an LMNA mutation associated with a new cardiac and non-cardiac phenotype.
    Charniot JC; Pascal C; Bouchier C; Sébillon P; Salama J; Duboscq-Bidot L; Peuchmaurd M; Desnos M; Artigou JY; Komajda M
    Hum Mutat; 2003 May; 21(5):473-81. PubMed ID: 12673789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel SBF2 missense mutation associated with a rare case of thrombocytopenia using whole-exome sequencing.
    Abuzenadah AM; Zaher GF; Dallol A; Damanhouri GA; Chaudhary AG; Al-Sayes F; Gari MA; AlZahrani M; Hindawi S; Al-Qahtani MH
    J Thromb Thrombolysis; 2013 Nov; 36(4):501-6. PubMed ID: 23334996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inherited progressive cardiac conduction disorders.
    Baruteau AE; Probst V; Abriel H
    Curr Opin Cardiol; 2015 Jan; 30(1):33-9. PubMed ID: 25426816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Characterization of a Novel Truncating Mutation in Lamin A/C Gene in a Family with a Severe Cardiomyopathy with Conduction Defects.
    Gerbino A; Bottillo I; Milano S; Lipari M; Zio R; Morlino S; Mola MG; Procino G; Re F; Zachara E; Grammatico P; Svelto M; Carmosino M
    Cell Physiol Biochem; 2017; 44(4):1559-1577. PubMed ID: 29197877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphorylation of Lamin A/C at serine 22 modulates Na
    Olaopa MA; Ai T; Chao B; Xiao X; Vatta M; Habecker BA
    Physiol Rep; 2021 Nov; 9(22):e15121. PubMed ID: 34806324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes.
    Park J; Levin MG; Haggerty CM; Hartzel DN; Judy R; Kember RL; Reza N; ; Ritchie MD; Owens AT; Damrauer SM; Rader DJ
    Genet Med; 2020 Jan; 22(1):102-111. PubMed ID: 31383942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.